IN2014DN09013A - - Google Patents

Info

Publication number
IN2014DN09013A
IN2014DN09013A IN9013DEN2014A IN2014DN09013A IN 2014DN09013 A IN2014DN09013 A IN 2014DN09013A IN 9013DEN2014 A IN9013DEN2014 A IN 9013DEN2014A IN 2014DN09013 A IN2014DN09013 A IN 2014DN09013A
Authority
IN
India
Application number
Inventor
Xizhong Huang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2014DN09013A publication Critical patent/IN2014DN09013A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9013DEN2014 2012-03-30 2014-10-28 IN2014DN09013A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261618215P 2012-03-30 2012-03-30
PCT/US2013/034214 WO2013148912A1 (en) 2012-03-30 2013-03-28 Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma

Publications (1)

Publication Number Publication Date
IN2014DN09013A true IN2014DN09013A (en) 2015-05-22

Family

ID=48142079

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9013DEN2014 IN2014DN09013A (en) 2012-03-30 2014-10-28

Country Status (11)

Country Link
US (2) US20150051252A1 (en)
EP (1) EP2830619A1 (en)
JP (1) JP2015512416A (en)
KR (1) KR20150002623A (en)
CN (1) CN104244949A (en)
AU (1) AU2013239624A1 (en)
CA (1) CA2865993A1 (en)
IN (1) IN2014DN09013A (en)
MX (1) MX2014011843A (en)
RU (1) RU2014143232A (en)
WO (1) WO2013148912A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015078931A1 (en) * 2013-11-27 2015-06-04 Oncoethix Sa Method of treating neuroblastomas using thienotriazolodiazepine compounds
EP3558266B1 (en) * 2016-12-21 2022-03-30 The Board of Regents of The University of Texas System Altertoxin ii as a selective inhibitor of ewing family of tumor cells
WO2020047113A1 (en) * 2018-08-28 2020-03-05 Cormedix Inc. Neuroblastoma treatment with taurolidine hydrolysis products

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044519A1 (en) * 2003-05-02 2005-09-14 Novartis Ag DERIVATIVES OF PIRIDIN-TIAZOL AMINA AND PIRIMIDIN-TIAZOL AMINA
PA8809001A1 (en) * 2007-12-20 2009-07-23 Novartis Ag ORGANIC COMPOUNDS
UA104147C2 (en) * 2008-09-10 2014-01-10 Новартис Аг Pyrrolidine dicarboxylic acid derivative and use thereof in the treatment of proliferative diseases
SG178454A1 (en) * 2009-08-17 2012-03-29 Intellikine Inc Heterocyclic compounds and uses thereof
EP2723733A1 (en) * 2011-06-21 2014-04-30 Novartis AG Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
EA030465B1 (en) * 2011-07-01 2018-08-31 Новартис Аг Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
US20140235630A1 (en) * 2011-09-30 2014-08-21 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for the treatment of proliferative diseases
US8980259B2 (en) * 2012-07-20 2015-03-17 Novartis Ag Combination therapy

Also Published As

Publication number Publication date
CN104244949A (en) 2014-12-24
CA2865993A1 (en) 2013-10-03
US20160151344A1 (en) 2016-06-02
EP2830619A1 (en) 2015-02-04
JP2015512416A (en) 2015-04-27
WO2013148912A1 (en) 2013-10-03
RU2014143232A (en) 2016-05-27
US20150051252A1 (en) 2015-02-19
MX2014011843A (en) 2014-12-10
KR20150002623A (en) 2015-01-07
AU2013239624A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
BR112014017635A2 (en)
BR112014017614A2 (en)
BR112014019228A2 (en)
BR112014017625A2 (en)
BR112014017592A2 (en)
AR092201A1 (en)
BR112014017638A2 (en)
BR112013027865A2 (en)
BR112014017634A2 (en)
BR112014017588A2 (en)
BR112014017618A2 (en)
BR112014013184A8 (en)
BR112014019147A2 (en)
BR112014017630A2 (en)
BR112014017621A2 (en)
BR112014017622A2 (en)
BR112014017627A2 (en)
BR112014017623A2 (en)
BR112014017631A2 (en)
BR112014017636A2 (en)
BR112014017667A2 (en)
BR112014023174A2 (en)
BR112014017671A2 (en)
BR112014017596A2 (en)
BR112014017591A2 (en)